These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29371192)

  • 21. Implementation of a prioritized scoring tool to improve time to pharmacist intervention.
    Harvin A; Mellett JJJ; Knoell D; Mirtallo J; Naseman RW; Brown N; Tubbs CR
    Am J Health Syst Pharm; 2018 Jan; 75(1):e50-e56. PubMed ID: 29273613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
    Han HK; An H; Shin KH; Shin D; Lee SH; Kim JH; Cho SH; Kang HR; Jang IJ; Yu KS; Lim KS
    Ther Drug Monit; 2014 Oct; 36(5):606-11. PubMed ID: 24577126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.
    Prybylski JP
    Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin administration: the impact of multidisciplinary interventions.
    Crowley RK; Fitzpatrick F; Solanki D; FitzGerald S; Humphreys H; Smyth EG
    J Clin Pathol; 2007 Oct; 60(10):1155-9. PubMed ID: 17293388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a Pharmacist-Initiated Vancomycin Monitoring Program.
    Smith AP; Millares-Sipin CA; James M; Cohen H
    Consult Pharm; 2016 Sep; 31(9):505-10. PubMed ID: 27636875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intervention to improve the timing of vancomycin levels.
    Melanson SE; Mijailovic AS; Wright AP; Szumita PM; Bates DW; Tanasijevic MJ
    Am J Clin Pathol; 2013 Dec; 140(6):801-6. PubMed ID: 24225746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
    Qian X; Du G; Weng C; Zhou H; Zhou X
    Int J Infect Dis; 2017 Jul; 60():17-22. PubMed ID: 28457752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between vancomycin dosage and serum trough vancomycin concentrations in pediatric patients with cystic fibrosis.
    Durham SH; Garza KB; Eiland LS
    Am J Health Syst Pharm; 2016 Jul; 73(13):969-74. PubMed ID: 27325878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trough-only monitoring of serum vancomycin concentrations in neonates.
    Shackley F; Roberts P; Heath P; Bowler I; Saunders NJ
    J Antimicrob Chemother; 1998 Jan; 41(1):141-2. PubMed ID: 9511053
    [No Abstract]   [Full Text] [Related]  

  • 31. Vancomycin serum trough concentration vs. clinical outcome in patients with gram-positive infection: a retrospective analysis.
    Cao G; Liang X; Zhang J; Zhou Y; Wu J; Zhang Y; Chen Y; Huang J; Liu X; Yu J
    J Clin Pharm Ther; 2015 Dec; 40(6):640-4. PubMed ID: 26383121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
    Momattin H; Zogheib M; Homoud A; Al-Tawfiq JA
    Chemotherapy; 2016; 61(1):3-7. PubMed ID: 26555724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.